Effect of ergot alkaloids on serum prolactin in non-psychotic organic brain syndrome of the elderly

R. J. Gross, C. E. Eisdorfer, H. S. Schiller, G. Cox

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A compound of ergot alkaloids (Hydergine-Sandoz) or placebo was given to sixty elderly nursing home patients with non-psychotic organic brain syndrome. Subsequent to 12 weeks of treatment, the mean serum prolactin of the drug group was significantly lower than that of the placebo group. No correlation was found between changes in prolactin and changes in behavior using Sandoz Assessment of Clinical Status Rating Form-Geriatric. It may be that a higher dose of Hydergine with an accompanying greater drop in prolactin would be required to observe this effect.

Original languageEnglish
Pages (from-to)293-302
Number of pages10
JournalExperimental Aging Research
Volume5
Issue number4
StatePublished - Dec 1 1979
Externally publishedYes

Fingerprint

Ergot Alkaloids
Ergoloid Mesylates
Prolactin
Brain
Serum
Placebos
Nursing Homes
Geriatrics
Pharmaceutical Preparations
Placebo
Syndrome
Therapeutics
Drugs
Dose
Rating
Sixties

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology
  • Psychology(all)

Cite this

Gross, R. J., Eisdorfer, C. E., Schiller, H. S., & Cox, G. (1979). Effect of ergot alkaloids on serum prolactin in non-psychotic organic brain syndrome of the elderly. Experimental Aging Research, 5(4), 293-302.

Effect of ergot alkaloids on serum prolactin in non-psychotic organic brain syndrome of the elderly. / Gross, R. J.; Eisdorfer, C. E.; Schiller, H. S.; Cox, G.

In: Experimental Aging Research, Vol. 5, No. 4, 01.12.1979, p. 293-302.

Research output: Contribution to journalArticle

Gross, RJ, Eisdorfer, CE, Schiller, HS & Cox, G 1979, 'Effect of ergot alkaloids on serum prolactin in non-psychotic organic brain syndrome of the elderly', Experimental Aging Research, vol. 5, no. 4, pp. 293-302.
Gross, R. J. ; Eisdorfer, C. E. ; Schiller, H. S. ; Cox, G. / Effect of ergot alkaloids on serum prolactin in non-psychotic organic brain syndrome of the elderly. In: Experimental Aging Research. 1979 ; Vol. 5, No. 4. pp. 293-302.
@article{717526fb4ac9477983b0db641a2bd2c3,
title = "Effect of ergot alkaloids on serum prolactin in non-psychotic organic brain syndrome of the elderly",
abstract = "A compound of ergot alkaloids (Hydergine-Sandoz) or placebo was given to sixty elderly nursing home patients with non-psychotic organic brain syndrome. Subsequent to 12 weeks of treatment, the mean serum prolactin of the drug group was significantly lower than that of the placebo group. No correlation was found between changes in prolactin and changes in behavior using Sandoz Assessment of Clinical Status Rating Form-Geriatric. It may be that a higher dose of Hydergine with an accompanying greater drop in prolactin would be required to observe this effect.",
author = "Gross, {R. J.} and Eisdorfer, {C. E.} and Schiller, {H. S.} and G. Cox",
year = "1979",
month = "12",
day = "1",
language = "English",
volume = "5",
pages = "293--302",
journal = "Experimental Aging Research",
issn = "0361-073X",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

TY - JOUR

T1 - Effect of ergot alkaloids on serum prolactin in non-psychotic organic brain syndrome of the elderly

AU - Gross, R. J.

AU - Eisdorfer, C. E.

AU - Schiller, H. S.

AU - Cox, G.

PY - 1979/12/1

Y1 - 1979/12/1

N2 - A compound of ergot alkaloids (Hydergine-Sandoz) or placebo was given to sixty elderly nursing home patients with non-psychotic organic brain syndrome. Subsequent to 12 weeks of treatment, the mean serum prolactin of the drug group was significantly lower than that of the placebo group. No correlation was found between changes in prolactin and changes in behavior using Sandoz Assessment of Clinical Status Rating Form-Geriatric. It may be that a higher dose of Hydergine with an accompanying greater drop in prolactin would be required to observe this effect.

AB - A compound of ergot alkaloids (Hydergine-Sandoz) or placebo was given to sixty elderly nursing home patients with non-psychotic organic brain syndrome. Subsequent to 12 weeks of treatment, the mean serum prolactin of the drug group was significantly lower than that of the placebo group. No correlation was found between changes in prolactin and changes in behavior using Sandoz Assessment of Clinical Status Rating Form-Geriatric. It may be that a higher dose of Hydergine with an accompanying greater drop in prolactin would be required to observe this effect.

UR - http://www.scopus.com/inward/record.url?scp=0018648262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018648262&partnerID=8YFLogxK

M3 - Article

C2 - 520386

AN - SCOPUS:0018648262

VL - 5

SP - 293

EP - 302

JO - Experimental Aging Research

JF - Experimental Aging Research

SN - 0361-073X

IS - 4

ER -